Study shows benefits for bone growth in infants fed on InFat (Advanced Lipids)

A randomized, double-blind, controlled clinical trial on bone strength in term infants fed InFat, a high beta-palmitate formula, from Advanced Lipids, indicates InFat leads to significantly higher bone-strength parameters compared to a standard vegetable oil control. The trial studied the effect of 12 weeks feeding of infant formula with InFat on bone strength parameters. Bone strength results were measured by speed of sound, using quantitative ultrasound (QUS). The clinical trial included 83 term infants, 58 formula-fed and 25 breast-fed. The formula fed infants were assigned to a study group receiving formula with InFat, or to a control group receiving formula using standard vegetable oil mix. Bone-strength parameters were measured by QUS, plus anthropometric parameters.

At 12 weeks postnatal age, the mean bone strength measure of the InFat group was significantly higher than that of the control group (P = 0.049) and comparable with that of the breast-fed group. The trial was conducted by Ita Litmanovitz, MD., et al, at Meir Medical Center, Kfar Saba, Israel, and sponsored by Enzymotec. Results are published in Calcified Tissue International. See: "High Beta-Palmitate Formula and Bone Strength in Term Infants: A Randomized, Double-Blind, Controlled Trial." Ita Litmanovitz et al. Calcified Tissue International December 2012 DOI: 10.1007/s00223-012-9664-8